Medical product injection molding capability

FEATURES

• Disposable Video Laryngoscope Blade

  
  

  Beyond the Blade: How Ansix Tech’s Dedicated Disposable Video Laryngoscope Blade Project is Redefining Value, Quality, and Scalability in Airway Management

  Global Medical Manufacturing Hub

  In the high-stakes world of anesthesiology and emergency medicine, the disposable video laryngoscope blade has transitioned from a convenience item to a non-negotiable standard of care. The global shift away from reusable metal blades—driven by relentless concerns over cross-contamination, sterilization efficacy, and the logistical burden of reprocessing—has created a tidal wave of demand. Yet, for many medical device OEMs and healthcare systems, the path from concept to a reliably manufactured, cost-effective, high-volume disposable blade remains fraught with technical landmines.

  Enter Ansix Tech, a specialist contract manufacturer with over 28 years of deep-rooted experience in precision injection molding and medical device component production. While many molders claim expertise, Ansix Tech has taken the unusual step of launching a dedicated, internally funded project focused exclusively on the Disposable Video Laryngoscope Blade (DVLB). This is not merely a capacity expansion; it is a vertical integration of design, engineering, tooling, and mass production specifically optimized for one of the most demanding disposable medical devices on the market.

  This industry report dissects the anatomy of Ansix Tech’s DVLB program—from material science and mold flow analysis to production scalability, quality validation, and radical cost reduction strategies—demonstrating how the company solves perennial industry pain points and delivers tangible value to customers worldwide.

• Mold Description
  Product Materials:	PA12
  Mold Material:	S136ESR
  Number of Cavities:	1*1
  Glue Feeding Method:	Clod runner
  Cooling Method:	Water cooling
  Molding Cycle	22.5s

  
  

• WHY Ansix Tech Medical
  
  

  In-house Mould Design and Manufacturing with more than 29 years of experience

  Single-cavity to 32-cavity Ultra-precision and Micro Moulds

  Thin-wall moulding with wall thicknesses as thin as 50 microns

  Tolerance requirements of less than 1 micron depending on specific features

  Part weights from 0.0001g

  Multiple high-performance medical grade plastics

  ISO 9001 and ISO 13485 accreditations

  ISO Class 7 and 8 cleanrooms                                                                                                                                                                  
                                                            
• 

• CLEANROOM INJECTION MOULDING IN THE CHINA
  

  
  Ansix Medical delivers ultra-precise plastic injection moulding services, with sub-micron accuracy and surface finishes under 10 nm. Recognised as one of Europe’s most advanced medical moulding facilities, we process high-performance polymers like PEEK, COC, COP, PMMA, and PBT, from prototype to mass production.

  
  

  2-shot Moulding

  Micro Moulding

  Overmoulding

  Insert Moulding
• 

• 
• 
  MICRO MOULDING FOR EMERGING TECHNOLOGIES IN MEDICAL DEVICES
  

  
  Ansix Medical specialises in micro-moulded components for medical and pharma applications. Each production cell features robotic handling and in-line vision systems for real-time quality control and tray packaging, ensuring component integrity at every step.

  
  

  Bioabsorbable implant for cancer treatment

  PEEK implant

  Soft mist inhaler

  Injector pen

  Drug delivery system

  Microfluidics diagnostic system

• 
• ADVANCED INJECTION MOULDING TECHNIQUES

  
  We deliver high-precision, multi-material overmoulding with guaranteed shot-to-shot consistency—eliminating contamination and costly assembly. Capabilities include two-shot, 2K, and thin-wall moulding for complex, high-performance components.

  
  

• 
• HIGH QUALITY MICROFLUIDICS INJECTION MOULDING SERVICES  

  
  Ansix Medical engineers advanced microfluidic moulds with ±0.001 mm tolerances and integrated optics, combining cutting-edge injection moulding technology with rigorous quality assurance for high-performance analysis devices.
  

  MICROFLUIDICS & LAB-ON-A-CHIP MANUFACTURING

  At Ansix Tech, we deliver ultra-precise replication of microfluidic features—essential for manipulating capillary flow behaviours such as filling, pinning, and mixing—with sub-micron accuracy down to 0.5 microns. Our proven expertise in high-volume production of injection-moulded microfluidic and lab-on-a-chip devices includes advanced polymers such as PC, COC, and COP. We design and manufacture ultra-precision moulds capable of producing micro- to nano-scale channels, fully customised to your exact microfluidic requirements.
  

  
  

  HIGH ACCURACY MICROFLUIDICS DETAILS

  Our ultra-precise manufacturing processes support the integration of barcoded hydrogel beads, cells, and partitioning oil into single-cell emulsion droplets—crucial for single-cell gene expression and immune profiling in genomics. We engineer inline filters and support structures directly within the microchannel architecture, with feature sizes typically between 10 and 50 microns, enabling precise flow control and cell selection. Each moulding solution is custom-developed to ensure flawless surface replication and exceptional feature definition at the micro-scale.
  

  INTEGRATED OPTICS

  Our integrated optics enable continuous capillary flow to ensure 100% filling of inspection chambers, supporting precise optical laser detection via Frustrated Total Internal Reflection (FTIR) to identify magnetic nanoparticles.

  
  

  Through extensive research into tool insert materials, manufacturing processes, and microfluidic production techniques, our integrated optics—traditionally machined in nickel inserts—can now be produced in hardened stainless steel (50 Rc), meeting the demands of high-volume component moulding.

  
  Looking for an ISO 9001 – 13485 UK manufacturer with facilities in the UK and South East Asia for your Microfluidics or Lab-on-a-chip projects?
  
  

  If you have any plans related to Medical product injection molding capability , you can contact us at any time. We will turn your ideas into reality, let you realize your dreams, and obtain large orders from the market. Our contact information is info@ansixtech.com. Or contact our CTO, mail: stephen@ansixtech.com 

  
  
  

  
  

• 
• Bioresorbable Implant.  

  
  Cancer Treatment
  
  
  

  
  

• 
• Micro Nozzle 

  
  0.05 Orifice
  
  
  

  
  

• 
• PEEK Implant

  
  50 micron wall section
  
  
  

  
  

• 
• Microfluidic chip

  
  25 nm surface finish with integrated optic features.
  
  
  

  
  

• 
• Micro Optic 2 Shot

  
  Micro Medical Imaging System
  
  
  

  
  

• 
• PEEK Bone Implant

  
  Replacing Titanium
  
  
  

  
  

• 
• 
  
  Medical Bone Implant

  
  Looking for a ISO 13485 & 9001 certified China and UK specialist in Injection Moulding & Micro Moulding with cleanroom manufacturing?
  
  
  
  
  
  

  
  

• 
• 
  

  Surgical Equipment

  
  

  Drug Delivery/Minimally Invasive Drug Delivery Devices

  
  

  Delivery Systems

  
  
  
  
  
  

  
  

• 
• 
  

  Catheters and delivery systems
  
  

  Closed-loop devices (femoral artery and vein access)
  
  

  Trans-access introducer

  
  

  
  
  
  
  
  

  
  

• 
• 
  

  Wearable devices

  Portable syringes

  Insulin pens

  
  

  
  

  
  
  
  
  
  

  
  

• 
• 
  

  Respiratory system

  Air filter

  Dry powder inhaler

  
  

  
  

  
  
  
  
  
  

  
  

• 
• 
  

  IV Devices and Connectors

  Vein Catheters and Components

  IV Connectors and Components

  
  

  
  

  
  
  
  
  
  

  
  

• 
• 
  

  Drug dispensing/management system

  Remote flying squirrel

  Casings for various devices and displays

  Drug dispensing system

  
  

  
  

  
  
  
  
  
  

  
  

• 
• 
  

  Molecular and Immunoassays

  Molecular Diagnostic Consumables Disk

  Immunoassay Component Consumables

  
  

  
  

  
  
  
  
  
  

  
  

• 
• Ansix Medical product injection molding capability

  
  

  Ansix Tech Launches Integrated Medical Injection Molding Initiative: Redefining Value, Quality, and Cost Efficiency in Precision Healthcare Manufacturing

  In an era where medical device innovation demands ever-greater precision, regulatory rigor, and cost competitiveness, one company is rewriting the rules of engagement. Ansix Tech Limited, a global leader in injection molding solutions with over 28 years of manufacturing heritage, has formally launched a comprehensive Medical Product Injection Molding Capability initiative. This strategic expansion encompasses dedicated projects across disposable laryngoscope blades, endoscopic components, diagnostic instrument housings, and a growing portfolio of high-precision medical consumables. Backed by ISO 13485:2016 certification, a fully integrated manufacturing ecosystem spanning four production bases across China and Vietnam, 260 injection molding machines, and more than 1,200 employees—including over 200 specialized designers—Ansix Tech is positioning itself as the strategic co-engineering partner that medical OEMs have long sought.

   

  Project Initiation: Building Value from the First Engagement

  For Ansix Tech, a medical injection molding project does not begin with a purchase order for steel. It begins with a collaborative partnership grounded in what the company terms its “co-engineering” philosophy. This approach invites clients to engage from the earliest concept stage, ensuring that the final product is both technically robust and economically optimized from the outset. Industry research indicates that approximately 70% of a product’s manufacturing cost is locked in during the initial design phase, and Ansix Tech’s front-loaded engineering approach systematically captures cost-saving opportunities before a single line of mold design is drawn.

   

  At project initiation, Ansix Tech engineers conduct a comprehensive analysis of client requirements, market demands, and regulatory standards. The company holds ISO 13485 certification for medical devices, ISO 9001, IATF 16949, and ISO 14001, ensuring that every action is framed within a quality management system designed for regulatory compliance. For medical applications, this includes detailed analysis of intended use environments, sterilization methods—autoclave, gamma radiation, ethylene oxide, or chemical agents—and the specific regulatory pathway the final product must follow, whether FDA 510(k), CE MDR under the European Medical Device Regulation, or NMPA approval in China.

   

  The disposable laryngoscope blade market serves as a compelling case study for this strategic approach. The global disposable laryngoscope blades and handles market was estimated at USD 794.31 million in 2025, projected to reach USD 853.29 million in 2026, and expected to hit USD 1,184.77 million by 2032 at a compound annual growth rate of 5.87%. Behind these figures lies a fundamental shift in clinical practice—healthcare facilities worldwide are transitioning from traditional reusable equipment to single-use alternatives that eliminate the risk of cross-contamination. Yet with opportunity comes formidable challenges. The disposable anesthetic laryngoscope is widely recognized as one of the most challenging injection molding products in the medical device category. The blade must incorporate curved, anatomically contoured geometry matching human pharyngeal and laryngeal structures across multiple sizes—from neonatal 0# models with wall thicknesses controlled within 1.2 mm to adult 4# configurations requiring enhanced strength and rigidity. It must integrate mounting positions for sensors, fiber optic channels, and circuit interfaces while maintaining a fully sealed structure to prevent external contamination, and achieve optical transparency sufficient for clinical visualization while withstanding ethylene oxide sterilization without degradation—with residual ethylene oxide after sterilization limited to ≤10 μg/g.

   

  Ansix Tech’s integrated ecosystem—encompassing design, engineering, tooling, production, and logistics under a single unified technical philosophy—allows it to eliminate the friction typically found between material suppliers, mold makers, and production processors. Every decision from the outset is aligned with the final product‘s performance, regulatory compliance, and total cost of ownership.

   

  Customer Value Proposition: Beyond Traditional Supply Chain Relationships

  What distinguishes Ansix Tech from conventional manufacturing partners is not merely its longevity in the industry but its fully integrated, end-to-end approach. Unlike fragmented service providers that operate in functional silos, Ansix Tech offers a unified platform encompassing design, engineering, tooling, production, and logistics, eliminating communication gaps and ensuring consistency from concept to delivery.

   

  The value delivered to customers manifests across multiple dimensions. First, technical expertise: with a track record of more than 30,000 mold sets delivered globally, the company possesses deep institutional knowledge across diverse medical device categories, from anesthesia needles and catheter connectors to complex diagnostic instrument housings and endoscopic snake bones. Second, scale and reliability: with four production bases, 260 injection molding machines ranging from 30 to 2,800 tons, and a total building area of approximately 200,000 square meters, the company possesses the infrastructure necessary to serve global medical OEMs with consistent quality and on-time delivery. Third, regulatory confidence: ISO 13485:2016 certification provides clients with the documented evidence required for FDA, CE, and NMPA submissions, significantly reducing the compliance burden on medical device manufacturers.

   

  Perhaps most critically, Ansix Tech addresses a persistent pain point in medical device manufacturing: fragmented supply chains where mold designers, material suppliers, and injection molders operate in isolation. Extended validation cycles that delay time-to-market and cost structures that struggle to achieve the per-unit economics required for disposable devices to succeed on a global scale have long plagued the industry. Ansix Tech’s integrated model directly confronts these challenges, ensuring that every decision is aligned with the final product’s performance, regulatory compliance, and total cost of ownership.

   

  Material Science: The Foundation of Medical-Grade Performance

  The selection of raw materials for medical injection molding components is a science in itself, demanding rigorous adherence to biocompatibility standards and performance specifications. Every material selected must meet ISO 10993 biocompatibility testing and USP Class VI requirements, ensuring safety from biological incompatibility for production utilization. Common medical-grade polymer families include polycarbonate (PC) for its impact strength and optical clarity, polysulfone (PSU) and polyether ether ketone (PEEK) for high-temperature stability, and various grades of polyethylene (PE) and polypropylene (PP) for cost-effective disposable applications. For moving parts such as plungers and activation mechanisms, polyoxymethylene (POM) provides low friction and excellent dimensional stability, while cyclic olefin copolymer (COC) delivers superior transparency for optical applications.

   

  Ansix Tech engineers work closely with certified material suppliers to verify that each resin grade meets the specific requirements of the intended application. This includes analyzing shrinkage rates, flow characteristics, and thermal properties—each material introduces unique variables that directly impact mold design and process parameters. For high-volume disposable laryngoscope blade production, materials are typically selected from PC, COC, or specialized medical-grade copolymers that combine optical clarity with sterilization resistance. The verification process includes thermal aging tests at 120℃ for four hours to validate dimensional stability, biocompatibility testing per ISO 10993-1 standards, and, where applicable, pull-out force testing for insert-molded components.

   

  DFM and Mold Flow Analysis: Digital Engineering at Scale

  The cornerstone of Ansix Tech’s engineering workflow is the Design for Manufacturability (DFM) analysis. For medical components that may feature living hinges, ultra-thin walls, and complex internal channels for steering wires and optical fibers, manufacturability is paramount. Ansix Tech engineers scrutinize part designs for potential production pitfalls, examining wall thickness uniformity to prevent sink marks and differential shrinkage, verifying adequate draft angles to enable clean ejection without damaging delicate features, and identifying opportunities to simplify geometry—consolidating what might be multi-part metal assemblies into single injection-molded components.

   

  Advanced mold flow simulation software, including Moldflow and Moldex3D, is deployed to predict fill patterns, cooling behavior, and stress distribution before any steel is cut. This predictive capability ensures that the mold design is inherently matched to the process parameters and material behavior from the very beginning. Industry practice demonstrates that such simulations can identify pressure, temperature, and venting concerns early, guiding mold and cooling system design to prevent costly rework. The basic mold flow analysis typically includes simulation of the fill and pack phases to determine optimal gate location, gate sizes, runner balance, and process parameters.

   

  In the medical device context, DFM is not merely an optimization tool—it is a prerequisite for regulatory compliance. The ability to demonstrate that manufacturability was systematically considered and validated is increasingly required in regulatory submissions. Ansix Tech’s front-loaded DFM approach ensures that potential issues are identified and resolved in the digital domain, dramatically reducing the risk of downstream failures.

   

  Mold Design and Manufacturing: Precision Engineering for High-Volume Production

  The design of medical injection molds demands an extraordinary level of precision, with dimensional tolerances often specified in the ±0.01 mm range for critical features. Ansix Tech’s mold design philosophy is rooted in the understanding that a mold must be more than a precise negative of the part—it must be engineered for the specific material, the thermal dynamics of the production cell, and the rigors of high-cycle manufacturing.

   

  Parting Surface Optimization. The selection and design of parting surfaces directly impact part quality, flash formation, and cycle time. For medical components where cosmetic appearance is critical, curved parting surfaces are employed to hide parting lines on non-functional surfaces, ensuring that clinical visualization areas remain pristine.

   

  Gate and Runner Systems. The gate system—the entry point where molten plastic flows into the cavity—is a critical determinant of part quality. For high-volume medical production, Ansix Tech typically employs a combination of pin gates and hot runner systems. Pin gates with diameters as small as 0.8 mm are used for precision components, while hot runner systems with balanced flow channel lengths ensure consistent filling across all cavities. Runner diameter ratios are carefully controlled to maintain optimal flow balance, typically at 1:3 for medical-grade applications. For multi-cavity molds—commonly 8, 16, 32, or even 64 cavities for high-volume disposable devices—naturally balanced hot runner systems with equal-length flow channels are essential to prevent dimensional variation, flash, or short shots across different cavities.

   

  Cooling System Design. Cycle time in injection molding is dominated by cooling. Ansix Tech employs advanced conformal cooling channel designs, where cooling channels are contoured to follow the shape of the part rather than simply following straight-line drilling paths. Conformal cooling maintains a consistent distance between the cooling channel and the cavity wall—typically 2.5 mm—with flow rates of ≥8 L/min to ensure uniform thermal extraction. Industry studies indicate that optimized cooling can reduce cycle times by up to 30 percent, increase output by approximately one-third, and reduce manufacturing costs per part by a good 20 percent.

   

  Ejection Systems. The ejection system must extract the finished part from the mold without damaging delicate features, marking critical surfaces, or causing deformation. For medical components with thin walls or complex geometries, Ansix Tech engineers design ejection systems that distribute force evenly across the part, often using multiple ejector pins combined with air ejection or stripper plates to ensure clean, damage-free release.

   

  Mold Materials and Processing. The selection of mold steel directly impacts tool longevity, surface finish quality, and production consistency. For medical-grade tooling, Ansix Tech employs high-grade steels such as H13 or S136 stainless steel, which provide excellent corrosion resistance essential for cleanroom operations and extended production runs. Surface finishes are engineered to comply with VDI 3400 or SPI standards, ensuring correct optical and tactile properties for medical devices. Where required, PVD (Physical Vapor Deposition) or DLC (Diamond-Like Carbon) coatings are applied to reduce friction and wear on high-cavity tools.

   

  The mold manufacturing process follows a rigorous workflow. Rough cavity machining leaves a precise allowance for finishing, typically 0.15 mm, achieving surface roughness of Ra3.2. Finish machining employs diamond-coated ball-end milling cutters with feed rates as low as 0.05 mm/r and spindle speeds up to 18,000 rpm, maintaining sidewall perpendicularity within 0.003 mm per 50 mm of height. For features that cannot be machined directly, electrical discharge machining (EDM) is employed to create micro-holes as small as 0.3 mm in diameter with depth-to-diameter ratios of 10:1 and surface finishes of Ra0.8. EDM parameters—peak current of 3 A, pulse width of 2 μs, machining speed of 15 mm³/min—are precisely controlled, and multi-electrode replacement processes ensure dimensional consistency of ±0.002 mm.

   

  Heat treatment is a critical step in mold manufacturing. Ansix Tech employs vacuum quenching followed by cryogenic treatment at -196℃ for 24 hours to eliminate retained austenite, achieving final material properties that maximize tool life and dimensional stability over hundreds of thousands of production cycles.

   

  Validation and Quality Assurance: Rigorous Protocols for Regulatory Confidence

  Validation in medical injection molding follows the industry-standard IQ/OQ/PQ protocol framework—Installation Qualification, Operational Qualification, and Performance Qualification. This structured approach establishes documented evidence that the manufacturing process consistently produces parts meeting all specified requirements.

   

  Installation Qualification (IQ) verifies proper installation of injection molding machines, utilities, tooling, and software, complete with calibration records and environmental conditions verification. This includes confirming that the mold meets user requirement specifications, validating metal dimensions, ensuring the tool fits the molding machine and services are available, and confirming calibration of gauges and temperature monitoring equipment.

   

  Operational Qualification (OQ) demonstrates that the process operates within established specifications under expected production conditions. This includes performing first article inspection, running the process at both high and low setpoints, assessing capability and balance, conducting design of experiments (DOE) where required, establishing and confirming operating settings, and creating comprehensive documentation. Typically, OQ involves a two-hour run at the low setpoints of the molding process followed by a two-hour run at the high setpoints, thoroughly mapping the process window.

   

  Performance Qualification (PQ) simulates actual production conditions to prove that the mold and established methods can repeatedly produce acceptable product over extended production runs. For high-volume medical devices, PQ runs often span multiple shifts or days, generating statistical process control data that demonstrates process capability with CpK values typically ≥1.33 for critical dimensions.

   

  Beyond the standard IQ/OQ/PQ framework, Ansix Tech implements a comprehensive quality management system aligned with ISO 13485:2016 requirements. This includes risk-based change control, sterilization validation for applicable products, traceability systems that link every molded component to its production batch and process parameters, and continuous monitoring of process performance through statistical methods.

   

  Cleanroom manufacturing is an essential component of medical injection molding quality assurance. Ansix Tech conducts medical injection molding in ISO 14644-1 certified cleanrooms, typically ISO Class 7 or Class 8, with HEPA filtration, positive pressure differentials, validated environmental monitoring for particulates and microbial load, and strict personnel gowning protocols. These controlled environments prevent contamination of medical components during molding, assembly, and packaging.

   

  Cost Reduction Strategy: Engineering-Driven Value Creation

  Perhaps the most compelling dimension of Ansix Tech’s value proposition is its systematic approach to cost reduction. The company’s corporate mission to “Make Our Customers Successful” is operationalized through a multi-pronged strategy that attacks cost at every stage of the manufacturing lifecycle, without compromising quality or regulatory compliance.

   

  Design-Led Cost Reduction. Ansix Tech’s front-loaded engineering approach is its most powerful cost-saving tool. With approximately 70% of a product’s manufacturing cost locked in during the initial design phase, the company’s early-stage DFM analysis identifies and eliminates cost drivers before tooling begins. This includes opportunities to simplify geometry, reduce part count by consolidating assemblies, optimize wall thickness for faster cycles, and select materials that balance performance with cost.

   

  Material Cost Optimization. Through deep expertise in medical-grade polymers and long-standing relationships with certified material suppliers, Ansix Tech engineers help clients select materials that meet all biocompatibility and performance requirements at the lowest possible cost. This includes evaluating alternative resin grades with similar properties, optimizing material utilization through runner design and part layout, and, for high-volume programs, negotiating volume-based pricing through centralized material purchasing across multiple customer programs.

   

  Process Efficiency and Cycle Time Reduction. Cycle time is the single largest driver of per-part cost in injection molding. Ansix Tech’s process engineers employ scientific molding techniques to systematically reduce cycle time while maintaining process stability and part quality. Industry benchmarks indicate that advanced process optimization can reduce cycle time by 20-30 percent, with corresponding reductions in per-part cost. For multi-cavity molds producing high-volume disposable devices, even modest cycle time reductions translate into substantial annual savings. Modern cooling system designs—including conformal cooling enabled by additive manufacturing—can reduce cooling time by 44 percent or more, as documented in recent industry case studies.

   

  Multi-Cavity Tooling Economics. For high-volume medical programs, multi-cavity molds dramatically reduce per-part cost through tooling amortization and increased output per machine hour. Ansix Tech designs and builds molds with cavity counts optimized for the customer’s annual volume requirements, balancing initial tooling investment against ongoing production efficiency.

   

  Waste Reduction and Scrap Minimization. In medical injection molding, scrap is not merely a cost issue—scrapped parts represent wasted materials, machine time, and, most critically, potential regulatory exposure if defective parts enter the supply chain. Ansix Tech’s process control systems maintain scrap rates well below industry averages through real-time monitoring, automated reject handling, and systematic root cause analysis for any deviation.

   

  Supply Chain Integration. By controlling the entire manufacturing ecosystem—from design and material procurement through molding, assembly, and logistics—Ansix Tech eliminates the markup and coordination costs associated with fragmented supply chains. Customers benefit from a single point of accountability and a unified cost structure that reflects end-to-end efficiency rather than cumulative supplier margins.

   

  Production Capacity and Delivery Assurance

  With 260 injection molding machines ranging from 30 to 2,800 tons across four production bases, Ansix Tech possesses the installed capacity to serve the world‘s largest medical device manufacturers while maintaining the flexibility to accommodate rapid scale-up for new product launches. The company’s strategic manufacturing footprint across China and Vietnam provides customers with geographic diversification and supply chain resilience.

   

  Delivery assurance is built into every aspect of Ansix Tech’s operations. The integrated ecosystem eliminates handoff delays between separate suppliers, accelerating project timelines from design to delivery. Automated machining equipment achieves a 70% automation ratio, with an average of only two mold trials required before production readiness—dramatically faster than industry averages. For urgent customer needs, the company maintains dedicated rapid-response production cells that can be reconfigured to prioritize critical programs.

   

  Packaging and logistics are fully integrated into the manufacturing workflow. Finished components are packaged in cleanroom environments using validated packaging materials and methods appropriate for the sterilization method and distribution requirements. Traceability systems link every package to its production batch and quality records, supporting regulatory requirements for device history records and complaint investigations.

   

  Industry Experience and Proven Reliability

  With over 28 years of injection molding heritage and more than 30,000 mold sets delivered globally, Ansix Tech brings proven reliability to every customer engagement. The company’s diversified customer base across automotive, medical and personal care, commercial communications equipment, mobile and wearable devices, and smart home products reflects the breadth and depth of its technical capabilities.

   

  In the medical sector specifically, Ansix Tech has established a track record of success across anesthesia needles, catheter connectors, diagnostic instrument housings, endoscopic snake bones, and now disposable laryngoscope blades. The company’s ISO 13485:2016 certification and comprehensive quality management systems provide clients with the regulatory confidence essential for FDA, CE, and NMPA submissions.

   

  The Road Ahead

  As the global medical injection molding market continues its strong growth trajectory—from $25.48 billion in 2024 to $27.32 billion in 2025 at a CAGR of 7.2%—the demand for strategic manufacturing partners capable of delivering precision, quality, and cost efficiency at scale will only intensify. Ansix Tech’s Medical Product Injection Molding Capability initiative positions the company at the forefront of this expanding market.

   

  Industry leaders are increasingly moving away from fragmented vendor models and toward partners that deliver precise molds, integrated systems, and long-term technical support. Ansix Tech’s integrated ecosystem—combining over 28 years of experience, ISO 13485 certification, 260 injection molding machines, more than 200 designers, and a track record of 30,000 mold sets—represents exactly the kind of strategic partnership that medical device OEMs require to compete in today’s demanding healthcare marketplace.

   

  For medical device manufacturers seeking to reduce costs, accelerate time-to-market, and ensure uncompromising quality, Ansix Tech offers a proven pathway from concept to cost-effective mass production. The company’s newly launched Medical Product Injection Molding Capability initiative is not merely an expansion of manufacturing capacity—it is a fundamental rethinking of what medical device supply chain partners can and should deliver.

   

  About Ansix Tech Limited

   

  Founded in Hong Kong in 1998, Ansix Tech Limited has evolved into a leading global provider of one-stop injection molding solutions, specializing in the design and manufacturing of injection molds and the mechanical design and production of injection-molded components. With ISO 9001, ISO 14001, IATF 16949, and ISO 13485:2016 certifications, four production bases across China and Vietnam, 260 injection molding machines, and over 1,200 employees, Ansix Tech serves customers across automotive, medical, consumer electronics, communications, and smart home industries.

   

  For more information, visit www.ansixtech.com.

   

  Source: Ansix Tech Limited. Industry market data sourced from published reports as cited.

   

  Media Contact

   

  Ansix Tech Limited

  Email: info@ansixtech.com

  Web: www.ansixtech.com